
MIT engineers create nanoparticles for delivering personalized cancer vaccines
The particles carry a customized dose of cancer antigens that can provoke a strong immune response against tumors.

The particles carry a customized dose of cancer antigens that can provoke a strong immune response against tumors.

Data supporting the expanded clearance came from the HALT study involving 130 patients.

Mezoo has turned a credit-card-sized chest patch into a monitoring platform used in more than 700 Korean hospitals and clinics.

Fox Chase Cancer Center researchers identified a potential therapeutic target for pancreatic cancer after showing that tumor growth can be slowed and immune suppression can be reduced in preclinical trials by blocking a particular protein, called anoctamin 6 (ANO6).

A patient has undergone pioneering stem-cell therapy to treat Parkinson’s disease, the Japanese drugmaker behind the treatment said on Friday, in a world first following its conditional approval in the country.

The immune system may recognize a cancer cell and still fail to destroy it. In a recent study, researchers at Hiroshima University and their international collaborators found that hyperactive YAP and TAZ (YAP/TAZ), two cancer-promoting proteins, were associated with genomic instability that may make cancer cells more recognizable to the immune system, while also increasing PD-L2, which helps the cells suppress T-cell attack.

A simple vaginal swab may one day help women with abnormal bleeding learn whether they have endometrial cancer without first going through a painful biopsy.